Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$9.38 USD
-0.34 (-3.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $9.45 +0.07 (0.75%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Precision BioSciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.32 | -111.64 | -30.60 | -109.01 | -92.88 |
Depreciation/Amortization & Depletion | 7.74 | 8.65 | 10.18 | 9.81 | 5.32 |
Net Change from Assets/Liabilities | -41.49 | 24.11 | 19.58 | -2.01 | -2.36 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.95 | 33.13 | -10.02 | 13.82 | 18.90 |
Net Cash From Operating Activities | -84.11 | -45.75 | -10.85 | -87.39 | -71.02 |
Property & Equipment | -1.85 | -3.32 | -5.05 | -5.03 | -24.67 |
Acquisition/ Disposition of Subsidiaries | 8.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.32 | 0.00 | -0.75 | 0.00 | 0.00 |
Net Cash from Investing Activities | 5.83 | -3.32 | -5.80 | -5.03 | -24.67 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.39 | 75.18 | 68.06 | 1.33 | 136.45 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -2.51 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 19.81 | 4.97 | 0.00 | 39.55 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -2.62 |
Net Cash from Financing Activities | 5.39 | 94.99 | 70.52 | 1.33 | 173.37 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -72.90 | 45.91 | 53.87 | -91.09 | 77.69 |
Cash at Beginning of Period | 189.58 | 143.66 | 89.80 | 180.89 | 103.19 |
Cash at End of Period | 116.68 | 189.58 | 143.66 | 89.80 | 180.89 |
Diluted Net EPS | -15.96 | -38.14 | -15.62 | -62.76 | -66.37 |
Fiscal Year End for Precision BioSciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -61.32 | -45.03 | -36.95 | -25.06 |
Depreciation/Amortization & Depletion | NA | 7.74 | 6.39 | 4.47 | 2.18 |
Net Change from Assets/Liabilities | NA | -41.49 | -44.44 | -31.76 | -15.01 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 10.95 | 7.40 | 11.64 | 6.42 |
Net Cash From Operating Activities | NA | -84.11 | -75.69 | -52.60 | -31.46 |
Property & Equipment | NA | -1.85 | -1.91 | -1.53 | -0.52 |
Acquisition/ Disposition of Subsidiaries | NA | 8.00 | 8.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -0.32 | -0.30 | -0.25 | -0.20 |
Net Cash from Investing Activities | NA | 5.83 | 5.79 | -1.78 | -0.72 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 5.39 | 2.56 | 2.59 | 0.74 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 5.39 | 2.56 | 2.59 | 0.74 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -72.90 | -67.35 | -51.78 | -31.44 |
Cash at Beginning of Period | NA | 189.58 | 189.58 | 189.58 | 189.58 |
Cash at End of Period | NA | 116.68 | 122.23 | 137.79 | 158.13 |
Diluted Net EPS | NA | -3.95 | -2.10 | -3.00 | -6.91 |